Darapladib did well in animal studies but not as effective in human study
(dailyRx News) Drug trials exist for a reason — so researchers can check a medication’s effectiveness and side effects to be sure it’s safe for human consumption. Unfortunately, not all medications live up to their initial promise.
The latest medication to disappoint researchers is darapladib.
In a recent large study, patients who took the drug were not much less likely to have heart attacks, did not have notably fewer strokes and were not significantly less likely to die for any reason, compared to those taking placebo (sugar pills).
Read more from RxWiki HERE.
Posted in Industry News